SHANGHAI,Dec. 9,2024-- December 8,2024,Abbisko Therapeutics (HKEX: 02256) announced the presentation of preliminary Phase 2 study results for pimicotinib (ABSK021) in patients with chronic Graft-versu
Front-end and Back-end Segments Projected to Support Consecutive Growth from 2024 through 2026 TOKYO,Dec. 9,2024--Global sales of total semiconductor manufacturing equipment by original equipment man
GUANGZHOU,China,Dec. 9,2024-- As the beating hub of Asia\'s furniture manufacturing industry,CIFM / interzum guangzhou 2025,organised by Koelnmesse and China Foreign Trade Centre Group,Ltd.,is set to
BEIJING,SHANGHAI and BOSTON,Dec. 9,2024-- Jacobio Pharma (1167.HK),a clinical-stage oncology company dedicated to developing therapies toward undruggable targets,today presented preliminary Phase I da
SAN FRANCISCO and SUZHOU,China,Dec. 9,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua
THUWAL,Saudi Arabia,Dec. 9,2024-- Researchers from KingAbdullah University of Science and Technology (KAUST),Saudi Arabia\'s leading applied research university,in collaboration with Aeon Collective,a
